Jump to Navigation
Home

Main menu

  • Home
  • News
  • Markets Map
  • Sentiments
  • Topics
  • Data
  • Comments
  • Images
  • Blog
  • About

Secondary menu

  • Latest News
  • Top Rated
  • Most Popular
  • Archive
  • Discussions
  • European stocks rise in muted trading
  • Cell phone charged in 20 seconds?
  • EU taps top oil traders for help in price-fixing probe
  • Bucks: Challenge What You Think You Know
  • When You Cut Trash Collection To Every Two Weeks, Parents...
  • Reasons To Keep Vanguard Dividend Appreciation ETF In...
  • Linn Energy's Annual Report Bodes Well For 2013
  • Isis Pharmaceuticals' Management Presents at UBS...
  • 3 Financial Sector Stocks With Recent Intensive Insider...
  • Who is RBS? Royal BS... or the Royal Bank of Scotland

    Dividend Aristocrats Can Still Provide High Income

    Thu, 10/21/2010 - 11:10 EDT - Seeking Alpha
    • Avi Morris
    • JNJ
    • LEG
    • LLY
    • PBI
    • RPM

    Avi Morris submits:During these times with low interest rates, it's difficult to find decent yields for investment. Dividend Aristocrats (companies with a minimum of 25 consecutive years of higher annual dividends) are an excellent place to look. But yields have fallen, making it difficult to find yields over 4%. Below are 5 Dividend Aristocrats for consideration. (1) Eli Lilly (LLY) -- LLY is one of the largest, global pharmaceutical companies. Its yield has been high (above 5%) for months because it faces patent expiration on key drugs. So stockholders have to wait for FDA approval which creates uncertainty. Just today (April 20), the FDA called for a new study on the experimental diabetes drug Bydureon (delaying its approval) which LLY developed with another company! Because of uncertainty, LLY has been very cautious about increasing its dividend. This week the 49¢ dividend was declared for Q4 (providing a 5.4% yield), the same paid for 8 consecutive quarters. Thus the annual dividend for 2010 (with good earnings coverage) of $1.96 will equal last year's and LLY will be removed from the group when S&P makes its annual review in December. But LLY has paid an annual dividend since 1885, has a strong balance sheet, substantial foreign sales and more drugs in the pipeline. Complete Story »

    • Original article
    • Login or register to post comments
     

    Related

    • Eli Lilly's 6% Yield Is Tempting ...

      Avi Morris submits:I bought Eli Lilly (LLY) stock in 1993 because it had a 5¼% yield, similar to what banks were paying. The 1990s were a good time and the stock did well.

    • Eli Lilly: An High-Yield Investment for the Very Brave

      Avi Morris submits:I bought Eli Lilly (LLY) in 1993 and have seen the good and bad. The investment did well in the 1990s, but at the start of the last decade it suffered after the loss of patent protection on its main drug, Prozac. The company grew with newer drugs and this Dividend Aristocrat extended its streak of raising dividends. But the chart below shows that the decade was dreary, with the stock falling more than 50%.

    • Amylin CEO Sees Break With Lilly On Diabetes Drug As A Plus For Shareholders

      By The Burrill Report: By Marie Daghlian

    • Amylin: Shares Rise Despite Drug Approval Delay

      Zacks.com submits: The FDA recently issued a complete response letter delaying the approval of Amylin Pharmaceuticals, Inc. (AMLN), Eli Lilly and Co. (LLY) and Alkermes, Inc.’s (

    • Track Records for Select Dividend Aristocrats

      Avi Morris submits:I own four S&P 500 Dividend Aristocrats which I bought years ago, before the lists were made public, providing an opportunity to examine long term results.

    • Merck Discontinues Study of Experimental Anticlotting Drug: Biotech's Latest Troubles

      The Burrill Report submits: Merck (MRK) said it was discontinuing a study of its experimental anticlotting drug vorapaxar in patients with acute coronary syndrome after a data safety monitoring board reviewed safety and efficacy data and recommended the study be halted.

    • Six High Yielding Dividend Aristocrats for 2011

      Avi Morris submits:2010 has been a good year for many stocks. The Dow is up 8% after a stellar recovery last year. As usual, not all stocks participated equally. Generally, the Dividend Aristocrats have been laggards even though they have continued raising dividends. This article takes a look at 6 of the highest yielding Dividend Aristocrats, each with a minimum yield of 3%.

    • 4 Dividend Aristocrats with Attractive Yields for Value Investors

      Avi Morris submits:Low yields are common, especially with the return of risk averse thinking. Dividend Aristocrats remain an excellent source of investment ideas for obtaining higher yields. These companies have track records with a minimum 25 consecutive years of higher dividends, and many have streaks of 30-40 or more years.

    • Amylin, Alkermes Find Relief in Benign FDA Response Letter to Diabetes Drug

      EP Vantage submits:The dreaded FDA complete response letter, so often seen as a major setback and perceived negatively by investors in afflicted companies, was Monday welcomed with open arms by shareholders in Amylin Pharmaceuticals (AMLN) and Alkermes (

    • 26 Aristocrats Yielding More Than 10-Year Treasuries

      Scott's Investments submits:With fixed income yields continuing to drift lower, investors looking for higher yields may want to consider stable dividend paying stocks. However, it should be emphasized that there is no such thing as a free lunch - with higher yields comes added risk.

    Latest

    Macy’s Includes Free Mug In My Box Of Air Pillows
    Macy’s Includes Free Mug In My Box Of Air Pillows
    Dubai's Most Luxurious Hotel Is Giving Guests 24-Carat Gold iPads
    Dubai's Most Luxurious Hotel Is Giving...

    User login

    • Create new account
    • Request new password
    • Click on the icon to sign in with your social network login or enter your Bullfax.com login

    Our Blog

    • Quantative Easing: Not on the long run
    • China’s Insurers, PC Shipments, Bird flu Consequences and French taxes in Our Daily Round-Up for 05/20/2013
    • Yahoo buys start-up Tumblr for $1bn

    Markets Map

    Markets Map

    Follow Us

    Follow Us on Facebook, Twitter, Google Plus and RSS LinkedIn Facebook Twitter Google Plus RSS
    S&P 500: 1669.56 0.13% FTSE: 6755.63 1% Nikk.: 15360.81 1.45% DAX: 8455.83 0.68% HSI: 23493.029 1.75% FX: EUR/GBP: 1.1837 USD/EUR: 1.2874 JPY/USD: 102.425 Commodities: Gold: 1385.66

    Bullfax.com - Market News & Analysis 2008-2011
    Contact Us | About Us | Terms & Conditions

    Follow Us on Facebook, Twitter, Google Plus and RSS LinkedIn Facebook Twitter Google Plus RSS .

    Secondary menu

    • Latest News
    • Top Rated
    • Most Popular
    • Archive
    • Discussions